Expanded Newborn Screening Using Genome Sequencing for Early Actionable Conditions: results of the first 10,000 participants enrolled in the GUARDIAN study

Wendy K. Chung, Boston Children's Hospital, Boston, MA, United States; Alban Ziegler, CHU de Toulouse, Toulouse, Midi-Pyrenees, France; Carrie L. Koval-Burt, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, United States; Amber Begtrup, GeneDx, Gaithersburg, MD, United States; Katherine Langley, GeneDx, Henrico, VA, United States; Brenna M. Boyd, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, United States; Mehmet Bugrahan. Duz, Boston Children's Hospital, Boston, MA, United States; Lilian Cohen, Weill Cornell Medicine, New York, NY, United States; Alison J. Coffey, Illumina Inc., Cambridge, England, United Kingdom; Bethany Friedman, GeneDx, Gaithersburg, MD, United States; Rebecca Hernan, Boston Children's Hospital, Boston, MA, United States; Samuel Strom, Fabric Genomics, Monrovia, CA, United States; Laura Amendola, National Institute of Health, Seattle, WA, United States; Zhanzhi Hu, Columbia University, Oakland, CA, United States; Rudolph Leibel, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, United States; Kirsty McWalter, GeneDx, Gaithersburg, MD, United States; Kristin G. Monaghan, GeneDx, detroit, MI, United States; Kyle Retterer, Geisinger, Danville, PA, United States; Ryan J. Taft, Genetic Alliance, San Diego, CA, United States; Michele Caggana, Wadsworth Center / New York State Dept Health, Albany, NY, United States